A newly published study found that intravitreal injection of autologous CD34+ stem cells is well tolerated and feasible for treating loss of vision resulting from central retinal vein occlusion (CRVO) ...

Real-world evidence links higher injection frequency to better VA outcomes and reduced CST fluctuations, reinforcing ...

Learn about central retinal vein occlusion (CRVO), its causes, symptoms, diagnosis, and treatment options for vision loss.

Pompano Beach Clinic Details Non-Surgical Tear Trough Rejuvenation Options Pompano Beach, United States – February 18, 2026 / ...

Recommended retina specialists were denied access to Imran Khan in jail as doctors report improvement in his eye condition and plan possible second injection and further tests.

Zydus Lifesciences has launched Anyra, a biosimilar of Regeneron Pharmaceuticals’ Aflibercept 2 mg that is indicated for certain eye diseases.

Tirzepatide also linked to fewer complications, including those requiring interventions, compared with lifestyle intervention alone.

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

Dr Akanksha Agarwal explains how these popular procedures differ, who may consider them, costs in India, risks, and why ...

Septerna is poised for a pivotal catalyst with upcoming Phase 1 data for SEP-631, targeting mast cell-driven diseases via ...

Our faces were once seen as immutable windows to the soul — but today they’re something that can be made fashionable ...